Your trusted destination for CME, CPD & Medical Education across the Middle East.
The International Symposium on Ophthalmology and Glaucoma Research (ISOGR-26) is a premier hybrid event for professionals to explore the latest research, innovations, and clinical practices. This conference offers a platform for disseminating research, networking with peers, and advancing careers in ophthalmology.
The International Symposium on Ophthalmology and Glaucoma Research (ISOGR-26) is a two-day hybrid scientific symposium taking place on 3–4 October 2026 in Jeddah, Saudi Arabia, with virtual participation available. Organized by the International Society for Applied Research (ISAR), the symposium provides a platform for ophthalmologists, physicians, surgeons, researchers, scientists, and other healthcare professionals to explore recent developments in ophthalmology and glaucoma research. The scientific programme covers a broad range of topics spanning glaucoma diagnostics, ophthalmology clinical research, ocular therapeutics, retinal disorders, and cataract surgery. Participants will have opportunities to examine emerging technologies, current evidence, and innovative approaches that are shaping the diagnosis and treatment of ocular diseases. The glaucoma programme focuses on advances in diagnostic imaging, including optical coherence tomography and fundus autofluorescence, as well as the growing application of artificial intelligence and machine learning in ophthalmic diagnostics. Discussions also address emerging molecular and structural biomarkers that may support earlier detection, risk assessment, and monitoring of glaucoma progression. Clinical research in ophthalmology is another major component of the symposium. Sessions explore clinical trial design and methodology, recent trial findings, and the regulatory and ethical considerations involved in conducting research involving ophthalmic drugs, devices, and human participants. These discussions provide perspectives on how emerging evidence can influence treatment approaches and clinical guidelines. The programme also examines current and future directions in ocular therapeutics, including sustained-release drug delivery systems, injectable therapies, gene and cell-based treatments, and pharmacological developments for conditions such as glaucoma, uveitis, and dry eye disease. Retinal disorders are addressed through discussions of the mechanisms and management of age-related macular degeneration and diabetic retinopathy, together with surgical and medical approaches for vitreoretinal conditions. Participants can also explore emerging treatments for inherited retinal diseases and other complex retinal disorders. Advances in cataract surgery form another component of the programme, including modern phacoemulsification techniques, femtosecond laser-assisted cataract surgery, premium intraocular lenses, and strategies for preventing and managing surgical complications. These sessions highlight technological and clinical developments aimed at improving surgical precision and patient outcomes. In addition to scientific presentations, ISOGR-26 features keynote sessions, research presentations, workshops, and opportunities for professional networking. The hybrid format allows participants to engage either in person or virtually, supporting international knowledge exchange among researchers, clinicians, academics, and industry professionals. The symposium is intended for ophthalmologists, surgeons, physicians, researchers, scientists, and other healthcare professionals with an interest in ophthalmology, glaucoma, and related areas of eye care. Through its multidisciplinary scientific programme, ISOGR-26 provides opportunities to exchange research findings, explore emerging technologies, discuss clinical innovations, and consider future directions in ophthalmic research and practice.
Exploring the role of OCT, fundus autofluorescence, and other imaging modalities in the early detection and monitoring of glaucoma.
Discussion on how artificial intelligence algorithms are being used to analyze diagnostic data for improved accuracy and prediction of glaucoma progression.
Investigating new molecular and structural biomarkers for identifying at-risk individuals and tracking disease activity.
Best practices and innovative approaches in designing and implementing robust clinical trials for ophthalmic drugs and devices.
A review of significant findings from recent clinical trials and their impact on current clinical practice and treatment guidelines.
Navigating the regulatory landscape and ethical challenges in conducting ophthalmology research involving human subjects.
Examining sustained-release implants, injectable therapies, and other innovative methods for delivering medication to the eye.
An overview of the progress and potential of gene and cell therapies for treating inherited and acquired retinal diseases.
Updates on the latest pharmacological agents for managing conditions like glaucoma, uveitis, and dry eye disease.
Deep dive into the molecular and cellular mechanisms driving age-related macular degeneration and diabetic retinopathy.
Comparing the outcomes and techniques for managing retinal detachments, macular holes, and other vitreoretinal conditions.
Exploring next-generation treatments for inherited retinal diseases and other complex retinal disorders.
Discussion of femtosecond laser-assisted cataract surgery (FLACS) and other advanced techniques to improve surgical precision and safety.
Evaluating the performance and patient selection criteria for toric, multifocal, and extended depth of focus (EDOF) IOLs.
Strategies for preventing and managing common complications associated with cataract surgery to ensure optimal patient outcomes.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow
| Registration | Category | Valid Until | Price |
|---|---|---|---|
| Standard Presentation | Early Bird Entry | Sep 03, 2026 | USD 459 |
| Standard Presentation | Standard Entry | Sep 18, 2026 | USD 499 |
| Standard Presentation with Scopus Publication | Early Bird Entry | Sep 03, 2026 | USD 739 |
| Standard Presentation with Scopus Publication | Standard Entry | Sep 18, 2026 | USD 779 |
| Standard Presentation with Q2 Scopus Publication | Early Bird Entry | Sep 03, 2026 | USD 1,409 |
| Standard Presentation with Q2 Scopus Publication | Standard Entry | Sep 18, 2026 | USD 1,689 |
| Standard Presentation with Q3 Scopus Publication | Early Bird Entry | Sep 03, 2026 | USD 1,069 |
| Standard Presentation with Q3 Scopus Publication | Standard Entry | Sep 18, 2026 | USD 1,349 |
| Standard Listener | Early Bird Entry | Sep 03, 2026 | USD 269 |
| Standard Listener | Standard Entry | Sep 18, 2026 | USD 299 |
| Virtual Keynote Speaker Registration | Early Bird Entry | Sep 03, 2026 | USD 379 |
| Virtual Keynote Speaker Registration | Standard Entry | Sep 18, 2026 | USD 399 |
| Pre-recorded Video Submission | Early Bird Entry | Sep 03, 2026 | USD 299 |
| Pre-recorded Video Submission | Standard Entry | Sep 18, 2026 | USD 309 |
| Virtual Presentation | Early Bird Entry | Sep 03, 2026 | USD 309 |
| Virtual Presentation | Standard Entry | Sep 18, 2026 | USD 329 |
| Virtual Presentation with Scopus Publication | Early Bird Entry | Sep 03, 2026 | USD 629 |
| Virtual Presentation with Scopus Publication | Standard Entry | Sep 18, 2026 | USD 659 |
| Virtual Presentation with Q2 Ranking Publication | Early Bird Entry | Sep 03, 2026 | USD 1,239 |
| Virtual Presentation with Q2 Ranking Publication | Standard Entry | Sep 18, 2026 | USD 1,459 |
| Virtual Presentation with Q3 Ranking Publication | Early Bird Entry | Sep 03, 2026 | USD 899 |
| Virtual Presentation with Q3 Ranking Publication | Standard Entry | Sep 18, 2026 | USD 1,129 |
| Virtual Listener | Early Bird Entry | Sep 03, 2026 | USD 179 |
| Virtual Listener | Standard Entry | Sep 18, 2026 | USD 209 |